FIELD: pharmacology.
SUBSTANCE: antibacterial agent comprises a calcium lactate in the effective therapeutic dose. The treatment method comprises the enterally introduced antibacterial agents.
EFFECT: increasing the therapeutic agent and method activity by increasing the intestinal colonization resistance, eliminating dysbiosis and preventing morphofuctional disorders of the intestinal mucosa.
7 cl, 1 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBACTERIAL AGENT AND METHOD OF TREATING INTESTINAL YERSINIOSIS OR PSEUDOTUBERCULOSIS OR COLIBACTERIOSIS | 2013 |
|
RU2564014C2 |
| METHOD OF TREATING SYSTEMIC YERSINIA-CAUSED BACTERIAL INFECTIONS EXPERIMENTALLY | 2014 |
|
RU2563174C1 |
| METHOD FOR PREVENTION OF DEVELOPING BACTERIAL INTESTINAL INFECTION | 2012 |
|
RU2526806C2 |
| ANTI-HELICOBACTER AGENT AND METHOD FOR USE THEREOF | 2018 |
|
RU2713154C1 |
| METHOD OF STUDY OF GASTRIC AND INTESTINAL MICROBIOTA DURING SUPPRESSION OF COLONIZATION RESISTANCE OF GASTRIC MUCOSA OF EXPERIMENTAL ANIMALS | 2019 |
|
RU2745654C1 |
| METHOD FOR ERADICATION OF HELICOBACTER PYLORI BACTERIA IN EXPERIMENTAL HELICOBACTERIOSIS IN CONVENTIONAL WHITE MICE AND A MEANS FOR ITS IMPLEMENTATION | 2020 |
|
RU2746590C1 |
| AGENT FOR REDUCTION OF INTESTINAL MICROBIOCENOSIS IN CASE OF DYSBIOSIS | 2015 |
|
RU2593584C1 |
| HELICO-BACTERIOSIS SIMULATION METHOD | 2018 |
|
RU2690943C1 |
| METHOD OF F-1 ANTIGENE LOCAL ANTIBODIES DETECTION ASSOCIATED WITH ANTIYERSINIOSIS IMMUNOGENIC VACCINATION | 2006 |
|
RU2329506C1 |
| COMPOSITION WITH ANTI-INFECTIOUS ACTIVITY | 2012 |
|
RU2476205C1 |
